GridAI Technologies (GRDX) Intangibles (2015 - 2025)

GridAI Technologies' (GRDX) quarterly Intangibles came in at $21.8 million in Q4 2025, up 6353.06% on a QoQ basis from $338402.0 in Q3 2025.

GridAI Technologies (GRDX) Intangibles (2015 - 2025) Analysis & Trends

GridAI Technologies (GRDX) has 9 years of Intangibles data on file, last reported at $21.8 million in Q4 2025.

Quarterly Intangibles changed N/A year-over-year to $21.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $21.8 million (changed N/A YoY) and the FY2025 annual result came in at $21.8 million, changed N/A from the prior year.
Intangibles grew to $21.8 million in Q4 2025, from $338402.0 in the prior quarter.
In the past five years, Intangibles ranged from a high of $21.8 million in Q4 2025 to a low of $338402.0 in Q3 2025.
A 3-year average of $5.1 million and a median of $2.7 million in 2021 frame the typical range for Intangibles.
The widest YoY moves for Intangibles: up 0.0% in 2021, down 34.68% in 2021.
Tracing GRDX's Intangibles over 3 years: stood at $3.8 million in 2021, then slumped by 90.39% to $365486.0 in 2024, then jumped by 5874.86% to $21.8 million in 2025.
The last three Intangibles figures came in at $21.8 million (Q4 2025), $338402.0 (Q3 2025), and $365486.0 (Q1 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Intangibles (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	412.80 Mn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	1.31 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	266.00 Mn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	60.96 Mn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	-
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	93.49 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-
10	GridAI Technologies	6.06 Mn	6.06 Mn	-	21.84 Mn

Download Data